医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Aeonmed and Heyer Will Attend virtual.MEDICA Hand in Hand as the Leading Ventilator Suppliers In 2020

2020年11月12日 PM09:30
このエントリーをはてなブックマークに追加


 

BEIJING

Being the largest ventilator supplier in 2020, having supplied more than 50,000 units of ventilators around the world during the pandemic of COVID19, Beijing Aeonmed Co., Ltd has always had as their mission: “Guard life sincerely.” This became their solid promise to all the people. At the end of this year, with better healthcare solutions, the latest innovations and product developments, Aeonmed and Heyer Medical AG will attend the virtual.MEDICA 2020 as their 17th journey in these extraordinary medical events. Acquired by Aeonmed, the 137-yr-old Heyer will be reborn like a phoenix.

19 years – Founded in 2001, as a leading manufacturer in life support medical devices, Aeonmed has been accumulated fruitful experiences in R&D, manufacturing, sales and service for 19 years. When faced up to with the sudden outbreak of COVID-19, which had led to an exponential explosion in the demand of ventilators all over the world, Aeonmed took their social responsibility without a single pause, and thanks to the accumulation in the field and all the effort that everyone in Aeonmed made, they can try to save people as many as possible.

17 years – Medica is widely known as the largest medical equipment exhibition in the world, and 2020 is the 17th year that Aeonmed collaborates with this honored exhibition. virtual.MEDICA 2020 gives the opportunity for all the people who are still eager to communicate with each other in the field. As they keep investing on innovation and focusing on the feedback from customers, Aeonmed tries to bring new changes to everyone and has a positive attitude to link up with every collaborator.

137 years – Located in Bad Ems Germany, one of the most famous places for therme and spa, Heyer focuses on respiratory therapy for more than 100 years. After the wholly-owned acquisition, and fulfilling a bunch of comprehensive product lines, including solutions in OR and ICU, Heyer has started a brand-new journey with a more colorful future.

2020 is a year full of difficulties and opportunities. With dedication in medical developments and determination to guard lives sincerely, Aeonmed and Heyer will move forward hand in hand, shoulder to shoulder!

View source version on businesswire.com: https://www.businesswire.com/news/home/20201112005585/en/

CONTACT

Beijing Aeonmed Co., Ltd

Fenrir Zhang, International marketing department

0086-18631663156

fenrirzhang@aeonmed.com

http://www.aeonmed.com/english.php

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Sherlock Biosciences Strengthens Intellectual Property Portfolio in CRISPR-based Diagnostics Through Exclusive License Agreement with Tolo Biotech
  • New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint
  • Shape Therapeutics推出AAVid™衣壳发现平台和新型组织特异性AAV变异识别,解决基因治疗根本性的投药挑战
  • Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates
  • 三叶草生物发布其“S-三聚体”重组亚单位新冠候选疫苗 I 期临床研究积极结果